Capitol Family Office, Inc. Pfizer Inc Transaction History

Capitol Family Office, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	SELL	$39.39 - $51.28 $69,287 - $90,201	-1,759 Reduced 3.17%	53,754 $2.19 Million
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $67,509 - $88,126	-1,617 Reduced 2.83%	55,513 $0
Q3 2022 Oct 14, 2022	SELL	$43.76 - $53.42 $23,236 - $28,366	-531 Reduced 0.92%	57,130 $2.5 Million
Q2 2022 Jul 18, 2022	BUY	$46.53 - $55.17 $42,435 - $50,315	912 Added 1.61%	57,661 $3.02 Million
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $851,270 - $1.05 Million	18,607 Added 48.78%	56,749 $2.94 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $1.58 Million - $2.34 Million	38,142 New	38,142 $2.25 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Capitol Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Capitol Family Office, Inc. with notifications on news.